AIDS Treatment News
Table of Contents, October 26, 2001

• Tenofovir Approved: Broad Indication
  The FDA approved this important new anti-HIV drug on October 26, without restricting it to heavily pretreated patients.

• T-20 Small Program, CD4 <50, Will Enroll November 27 at 3:00 P.M.
  A small safety study for patients with a CD4 count under 50 and who cannot construct a viable antiviral regimen with approved drugs will open for registration on November 27. Only the first 56 physicians who call in, and have exactly three eligible patients each, will be accepted.

• Treatment News from Recent Conferences: Finding Web Reports
  Several important AIDS treatment conferences are reported extensively on different Web sites. Here is a way to quickly find what is new in particular areas of treatment and research.

• Anthrax, Bioterrorism Fears Stimulate Immune, Other Research
  The need for defense against biological warfare is pushing the development of new drugs that could fight many diseases. Many of these work by changing the body's immune response; others use different mechanisms. Some of the approaches now being studied are related to certain traditional or alternative treatments.
  Advertisement

• Africa: Funding Sought for Epidemic Control
  Over 75 members of Congress have called for new funding to fight epidemics worldwide, especially in developing countries.

• World AIDS Day Web Page
  Where to find information about World AIDS Day, December 1.

ISSN # 1052-4207

Copyright 2001 by John S. James. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used.